BMJ Open Respiratory Research · 2017 · 17 citations · 26 references
NursingBehavioral SciencesHealth AssessmentOutcomes ResearchPsychometricsDyspnea AssessmentDyspnea ManagementDyspnea Intensity ScalesDyspnea Quality AssessmentDyspnea Severity MeasurementDyspnea Severity ScalesDyspnea Symptom RatingInterview TranscriptsNumerical Rating ScalesPatient-reported Dyspnea Assessment
INTRODUCTION: The Numerical Rating Scale (NRS) is frequently used to assess patient-reported breathlessness in both a research and clinical context. A subgroup of patients report average breathlessness as worse than their worst breathlessness in the last 24 hours (paradoxical average). The Peak/End rule describes how the most extreme and current breathlessness influence reported average. This study seeks to highlight the existence of a subpopulation who give 'paradoxical averages using the NRS, to characterise this group and to investigate the explanatory relevance of the 'Peak/End' rule. METHODS: Data were collected within mixed method face-to-face interviews for three studies: the Living with Breathlessness Study and the two subprotocols of the Breathlessness Intervention Service phase III randomised controlled trial. Key variables from the three datasets were pooled (n=561), and cases where participants reported a paradoxical average (n=45) were identified. These were compared with non-cases and interview transcripts interrogated. NRS ratings of average breathlessness were assessed for fit to Peak/End rule. RESULTS: Patients in the paradoxical average group had higher Chronic Respiratory Questionnaire physical domain scores on average p=0.042). Peak/End rule analysis showed high positive correlation (Spearman's rho=0.756, p<0.001). CONCLUSIONS: The NRS requires further standardisation with reporting of question order and construction of scale used to enable informed interpretation. The application of the Peak/End rule demonstrates fallibility of NRS-Average as a construct as it is affected by current breathlessness. Measurement of breathlessness is important for both clinical management and research, but standardisation and transparency are required for meaningful results.
26
Mark B. Parshall, Richard M. Schwartzstein, Lewis Adams et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 1.8K citations · Full text
A measure of quality of life for clinical trials in chronic lung disease.
Gordon Guyatt, L Berman, Marie Townsend et al. · Thorax · 1987 · 1.7K citations · Full text
When More Pain Is Preferred to Less: Adding a Better End
Daniel Kahneman, Barbara L. Fredrickson, Charles A. Schreiber et al. · Psychological Science · 1993 · 1.5K citations